The objective of HIMPP is to clear the road of unjust IP obstacles, thus enabling the development of the most advanced and cost effective hearing instruments to the benefit of the hearing impaired.
HIMPP has acquired patents from Galler. Read more
HIMPP reduces running royalty from 3% to 1%, but increases partner entry share price as of 1 July 2017. Read more